Table 1: Open in new tab Patient... | Oxford Academic

Table 1:

Open in new tab

Patient characteristics

Patient characteristics	Non-diabetes	Controlled diabetes	Uncontrolled diabetes	P -values
HbA1c (%) ^a	5.4 ± 0.15	6.3 ± 0.14	9.9. ± 0.72 ^b	0.001
Age (years) ^a	67 ± 7	69 ± 9	66 ± 9	0.7
Male/female ( n )	7/3	8/2	8/2	1.0
Hypertension ( n )	10	10	10	1.0
Hypercholesterolaemia ( n )	10	10	10	1.0
Obesity (BMI > 30)	0	2	2	0.96
Atrial fibrillation ( n )	0	0	0	1.0
Patient blood glucose (mg/dl, pre-CPB) ^a	102 ± 3.6	135 ± 10	220 ± 15 ^b	0.0001
Patient blood glucose (mg/dl, during-CPB) ^a	152 ± 9.0	154 ± 12	206 ± 14 ^b	0.005
Preoperative insulin ( n ) (u/h ^a )	0 (0 ± 0)	4 (1.6 ± 1.9)	8 (6 ± 1) ^b	0.005
Intraoperative insulin ( n ) (u/h ^a )	2 (1.38 ± 1.31)	5 (5.5 ± 1.9)	8 (32.75 ± 7) ^b	0.0006
Duration of CPB (min) ^a	124 ± 13	126 ± 17	129 ± 24	0.89
Cross-clamp time (min) ^a	101 ± 13	103 ± 17	107 ± 22	0.9
CABG only ( n )	8	8	8	1.0
No. of grafts performed ( n )	3	3	3	1.0

Patient characteristics	Non-diabetes	Controlled diabetes	Uncontrolled diabetes	P -values
HbA1c (%) ^a	5.4 ± 0.15	6.3 ± 0.14	9.9. ± 0.72 ^b	0.001
Age (years) ^a	67 ± 7	69 ± 9	66 ± 9	0.7
Male/female ( n )	7/3	8/2	8/2	1.0
Hypertension ( n )	10	10	10	1.0
Hypercholesterolaemia ( n )	10	10	10	1.0
Obesity (BMI > 30)	0	2	2	0.96
Atrial fibrillation ( n )	0	0	0	1.0
Patient blood glucose (mg/dl, pre-CPB) ^a	102 ± 3.6	135 ± 10	220 ± 15 ^b	0.0001
Patient blood glucose (mg/dl, during-CPB) ^a	152 ± 9.0	154 ± 12	206 ± 14 ^b	0.005
Preoperative insulin ( n ) (u/h ^a )	0 (0 ± 0)	4 (1.6 ± 1.9)	8 (6 ± 1) ^b	0.005
Intraoperative insulin ( n ) (u/h ^a )	2 (1.38 ± 1.31)	5 (5.5 ± 1.9)	8 (32.75 ± 7) ^b	0.0006
Duration of CPB (min) ^a	124 ± 13	126 ± 17	129 ± 24	0.89
Cross-clamp time (min) ^a	101 ± 13	103 ± 17	107 ± 22	0.9
CABG only ( n )	8	8	8	1.0
No. of grafts performed ( n )	3	3	3	1.0

BMI, body mass index; HbA1c, haemoglobin A1c; CABG, coronary artery bypass grafting.

^a Data expressed as mean ± SD.

^b Uncontrolled diabetes versus non-diabetics.

Table 1:

Open in new tab

Patient characteristics

Patient characteristics	Non-diabetes	Controlled diabetes	Uncontrolled diabetes	P -values
HbA1c (%) ^a	5.4 ± 0.15	6.3 ± 0.14	9.9. ± 0.72 ^b	0.001
Age (years) ^a	67 ± 7	69 ± 9	66 ± 9	0.7
Male/female ( n )	7/3	8/2	8/2	1.0
Hypertension ( n )	10	10	10	1.0
Hypercholesterolaemia ( n )	10	10	10	1.0
Obesity (BMI > 30)	0	2	2	0.96
Atrial fibrillation ( n )	0	0	0	1.0
Patient blood glucose (mg/dl, pre-CPB) ^a	102 ± 3.6	135 ± 10	220 ± 15 ^b	0.0001
Patient blood glucose (mg/dl, during-CPB) ^a	152 ± 9.0	154 ± 12	206 ± 14 ^b	0.005
Preoperative insulin ( n ) (u/h ^a )	0 (0 ± 0)	4 (1.6 ± 1.9)	8 (6 ± 1) ^b	0.005
Intraoperative insulin ( n ) (u/h ^a )	2 (1.38 ± 1.31)	5 (5.5 ± 1.9)	8 (32.75 ± 7) ^b	0.0006
Duration of CPB (min) ^a	124 ± 13	126 ± 17	129 ± 24	0.89
Cross-clamp time (min) ^a	101 ± 13	103 ± 17	107 ± 22	0.9
CABG only ( n )	8	8	8	1.0
No. of grafts performed ( n )	3	3	3	1.0

Patient characteristics	Non-diabetes	Controlled diabetes	Uncontrolled diabetes	P -values
HbA1c (%) ^a	5.4 ± 0.15	6.3 ± 0.14	9.9. ± 0.72 ^b	0.001
Age (years) ^a	67 ± 7	69 ± 9	66 ± 9	0.7
Male/female ( n )	7/3	8/2	8/2	1.0
Hypertension ( n )	10	10	10	1.0
Hypercholesterolaemia ( n )	10	10	10	1.0
Obesity (BMI > 30)	0	2	2	0.96
Atrial fibrillation ( n )	0	0	0	1.0
Patient blood glucose (mg/dl, pre-CPB) ^a	102 ± 3.6	135 ± 10	220 ± 15 ^b	0.0001
Patient blood glucose (mg/dl, during-CPB) ^a	152 ± 9.0	154 ± 12	206 ± 14 ^b	0.005
Preoperative insulin ( n ) (u/h ^a )	0 (0 ± 0)	4 (1.6 ± 1.9)	8 (6 ± 1) ^b	0.005
Intraoperative insulin ( n ) (u/h ^a )	2 (1.38 ± 1.31)	5 (5.5 ± 1.9)	8 (32.75 ± 7) ^b	0.0006
Duration of CPB (min) ^a	124 ± 13	126 ± 17	129 ± 24	0.89
Cross-clamp time (min) ^a	101 ± 13	103 ± 17	107 ± 22	0.9
CABG only ( n )	8	8	8	1.0
No. of grafts performed ( n )	3	3	3	1.0

BMI, body mass index; HbA1c, haemoglobin A1c; CABG, coronary artery bypass grafting.

^a Data expressed as mean ± SD.

^b Uncontrolled diabetes versus non-diabetics.